Zealand Pharma A/SZealand Pharma A/SZealand Pharma A/S

Zealand Pharma A/S

No trades
See on Supercharts
Next report date
Report period
Q1 2024
EPS estimate
−0.60USD
Revenue estimate
‪1.32 M‬USD
Market capitalization
‪5.52 B‬USD
−1.85USD
‪−104.17 M‬USD
‪50.74 M‬USD
‪55.57 M‬
Beta (1Y)
1.09

About ZEALAND PHARMA A/S

CEO
Adam Sinding Steensberg
Headquarters
Soborg
Employees (FY)
253
Founded
1997
ISIN
DK0060257814
FIGI
BBG00276D296
Zealand Pharma A/S is a biotechnology company, which engages in the discovery, design, and development of peptide based medicines. Its products include Zegalogue and V-Go. The company was founded by Lars Hellerung Christiansen and Bjarne Due Larsen on April 1, 1997 and is headquartered in Soborg, Denmark.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of ZLDPF is 91.65 USD — it has increased by 6.26% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Zealand Pharma A/S stocks are traded under the ticker ZLDPF.
Zealand Pharma A/S is going to release the next earnings report on May 16, 2024. Keep track of upcoming events with our Earnings Calendar.
ZLDPF stock is 5.94% volatile and has beta coefficient of 1.09. Check out the list of the most volatile stocks — is Zealand Pharma A/S there?
ZLDPF earnings for the last quarter are 0.18 USD per share, whereas the estimation was −0.33 USD resulting in a 154.62% surprise. The estimated earnings for the next quarter are −0.57 USD per share. See more details about Zealand Pharma A/S earnings.
Zealand Pharma A/S revenue for the last quarter amounts to ‪41.79 M‬ USD despite the estimated figure of ‪8.19 M‬ USD. In the next quarter revenue is expected to reach ‪1.50 M‬ USD.
Yes, you can track Zealand Pharma A/S financials in yearly and quarterly reports right on TradingView.
ZLDPF stock has risen by 6.79% compared to the previous week, the month change is a 4.90% fall, over the last year Zealand Pharma A/S has showed a 174.40% increase.
ZLDPF net income for the last quarter is ‪−39.19 M‬ USD, while the quarter before that showed ‪10.48 M‬ USD of net income which accounts for −473.80% change. Track more Zealand Pharma A/S financial stats to get the full picture.
Today Zealand Pharma A/S has the market capitalization of ‪5.52 B‬, it has decreased by 3.58% over the last week.
No, ZLDPF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ZLDPF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Zealand Pharma A/S stock right from TradingView charts — choose your broker and connect to your account.
ZLDPF reached its all-time high on Mar 7, 2024 with the price of 111.44 USD, and its all-time low was 10.20 USD and was reached on Nov 21, 2013.
See other stocks reaching their highest and lowest prices.
As of Apr 30, 2024, the company has 253.00 employees. See our rating of the largest employees — is Zealand Pharma A/S on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Zealand Pharma A/S technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Zealand Pharma A/S stock shows the buy signal. See more of Zealand Pharma A/S technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Zealand Pharma A/S future price: according to them, ZLDPF price has a max estimate of 120.20 USD and a min estimate of 85.86 USD. Read a more detailed Zealand Pharma A/S forecast: see what analysts think of Zealand Pharma A/S and suggest that you do with its stocks.